COMMUNIQUÉS West-GlobeNewswire

LogicBio Therapeutics Announces Closing of Initial Public Offering

23/10/2018 - 22:05

CAMBRIDGE, Mass., Oct. 23, 2018 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet [...]

Clementia Announces Plan to Submit a New Drug Application for Palovarotene for the Treatment of FOP Based on Positive Phase 2 Results

23/10/2018 - 22:01

Updated Regulatory Strategy Based on 12-Week Flare-up Data from Completed Phase 2 Program and Consultation with the FDA NDA Submission Planned for the Second Half of 2019 MONTREAL, Oct. 23, 2018 (GLOBE NEWSWIRE) -- [...]

Clementia annonce son plan de soumettre une présentation de nouvelle drogue (New Drug Application) pour le palovarotène dans le traitement de la FOP à la suite de résultats positifs de la phase 2

23/10/2018 - 22:01

Mise à jour de la stratégie réglementaire en utilisant les données de poussées actualisées de la semaine 12 du programme de phase 2 et en consultation avec la FDA Soumission d’une NDA prévue pour le second semestre de [...]

Dermira Completes Patient Enrollment in Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis

23/10/2018 - 22:01

Topline efficacy and safety results anticipated by early April 2019 MENLO PARK, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity [...]

Krystal Biotech Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option

23/10/2018 - 22:01

PITTSBURGH, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech , Inc. (Nasdaq: KRYS) (the “Company”), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from [...]

HTG Molecular Diagnostics Announces the Institute of Oncology Research Has Adopted the HTG EdgeSeq Technology in its Genomics Facility

23/10/2018 - 22:01

HTG’s extraction-free, targeted next-generation sequencing technology adopted to support the IOR’s research and clinical trials in hematological cancers and solid tumors TUCSON, Ariz., Oct. 23, 2018 (GLOBE NEWSWIRE) -- [...]

iCAD Announces New Clinical Data on the Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment Demonstrating Positive Results

23/10/2018 - 20:01

Multi-center research presented at ASTRO 2018 shows IORT with the Xoft System is safe with low recurrence and low morbidity in the treatment of breast cancer Company marks 20 years of innovations in targeted cancer care [...]

OV - OV increases its share capital due to warrant exercise

23/10/2018 - 19:32

Hoersholm, Denmark, October 23, 2018 - Oncology Venture today announces that, as a consequence of an exercise of 40,000 warrants by current employee, the share capital in the company will increase by nominal DKK 2,000 [...]

Expert coalition provides recommendations to reduce adverse drug events from anticoagulants during care transitions

23/10/2018 - 19:00

Article appears in November 2018 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill. , Oct. 23, 2018 (GLOBE NEWSWIRE) -- Anticoagulants, medications that keep the blood from [...]

Fagron NV: Disclosure of received notification

23/10/2018 - 18:02

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 23 October 2018 - 6:00pm (CET) Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron [...]

EUROBIO SCIENTIFIC CERTIFIED ISO 13485 V2016

23/10/2018 - 17:47

EUROBIO SCIENTIFIC CERTIFIED ISO 13485 V2016 Eurobio Scientific has successfully upgraded its quality management systems in order to continue justifying CE marking of its products beyond 2019 Paris, October 23, 2018 - 5 [...]

EUROBIO SCIENTIFIC CERTIFIE ISO 13485 V2016

23/10/2018 - 17:47

EUROBIO SCIENTIFIC CERTIFIE ISO 13485 V2016 Eurobio Scientific a fait évoluer avec succès ses systèmes de management de la qualité pour continuer à justifier du marquage CE de ses produits au-delà de 2019 Paris, le 23 [...]

Transactions in relation to share buyback program

23/10/2018 - 17:14

Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

South Texas Veterans Health Care System Joins Test Validation Trial of bioAffinity’s CyPath® Lung

23/10/2018 - 17:00

SAN ANTONIO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the South Texas Veterans Health Care System (STVHCS), which is affiliated with the federal [...]

Tabula Rasa Healthcare to Announce Third Quarter 2018 Operating Results and Host Conference Call on Tuesday, November 6, 2018

23/10/2018 - 16:00

MOORESTOWN, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, will release its third quarter 2018 operating [...]

AroCell AB announces the appointment of a new CEO

23/10/2018 - 15:45

Michael Brobjer has been appointed new CEO of AroCell and will join the company December 8, 2018. Mr.Brobjer will provide AroCell with valuable expertise through his extensive experience in the pharmaceutical and [...]

Precipio Expands ICE COLD-PCR™ Menu for Breast, Colon and Endometrial Cancers

23/10/2018 - 15:15

Ultra-sensitive assays for PIK3CA exons 9 & 20 detect mutations that impact critical therapeutic decisions NEW HAVEN, Conn., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. ( NASDAQ: PRPO ), announced today that it [...]

Admera Health Expands Liquid Biopsy Offering to Include Detection of Copy Number Variation and Microsatellite Instability

23/10/2018 - 15:13

SOUTH PLAINFIELD, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- At CAP18, in Chicago, IL, Admera Health ( www.admerahealth.com ), unveiled an expansion to its next generation sequencing (NGS) based LiquidGx™ test for solid [...]

New U.S. Patent Allowance Granted to AXIM® Biotechnologies for Suppository Formulations Comprised of Cannabinoids

23/10/2018 - 15:10

NEW YORK, Oct. 23, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that the United States Patent [...]